Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical versus intravenous tranexamic acid in primary total hip arthroplasty
2013-004623-36Phase 2Completed
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tranexamic acid in osteoarthritis (OA) (2 arms), sponsored by Ziekenhuis Oost-Limburg. Primary endpoint: Postoperative blood loss. Started Nov 2013; status: completed.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2013-004623-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004623-36.